Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acitretin and Efalizumab in Chronic Plaque Psoriasis
NCT00707070Phase 4Unknown
- Sponsor
- Università degli Studi di Verona
- Start
- Sep 2008
- Primary completion
- Oct 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of acitretin in psoriasis, sponsored by Università degli Studi di Verona. Primary endpoint: Psoriasis Area and Severity Index 75 at 24 weeks. Status: unknown.
02
Drugs
acitretin
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT00707070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00707070.